Product containing precisely propranolol hydrochloride 2 mg/1 mL conventional release oral solution (clinical drug)
RxNorm 856719
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 856719 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Product containing precisely propranolol hydrochloride 2 mg/1 mL conventional release oral solution (clinical drug).
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
Semantic Clinical Drug (SCD):
Propranolol hydrochloride 2 mg/ML Oral Solution
(Atom ID: 12330669)
Full form of descriptor (FN):
Product containing precisely propranolol hydrochloride 2 mg/1 mL conventional release oral solution (clinical drug)
(Atom ID: 10316631)
Designated preferred name (PT):
Propranolol hydrochloride 2 mg/mL oral solution
(Atom ID: 10319785)
Patient Education
Propranolol (Infantile Hemangioma)
Propranolol oral solution is used to treat proliferating infantile hemangioma (benign [noncancerous] growths or tumors appearing on or under the skin shortly after birth) in infants 5 weeks to 5 months of age. Propranolol is in a class of medications called beta blockers. It works by narrowing the blood vessels already formed and by preventing new ones from growing.
[Learn More]
* Please review the disclaimer below.